Search for European Projects

5 European Projects Found

Searched on 125080 European Projects

 FINISHED 
Abstract 9Neuroimaging (NI) has enormous potential to improve the clinical care of patients with psychiatric disorders, but has yet to deliver. The PSYSCAN project will address this issue directly by developing a NI-based tool that will help clinicians resolve key clinical issues in the management of patients with psychotic disorders. Clinicians will use the tool to assess patients with a standard ...
Read Project

 24

 FINISHED 

Personalised Prognostic Tools for Early Psychosis Management (PRONIA)

Start date: Oct 1, 2013, End date: Sep 30, 2018,

Affective and non-affective psychoses have a major negative impact on human society. They account for 6.3% of the global burden of disease and cost €207 billion per year in Europe alone, making them the most expensive brain-related disorders and even more expensive than cardiovascular diseases. This socioeconomic burden is largely caused by two core disease features: onset in adolescence and early ...
Read Project

 13

 FINISHED 
"Chronic kidney disease is world wide a major cause of end-stage renal disease (ESRD). 800.000 patients in Europe and in the US, respectively, require long-term treatment initially with peritoneal dialysis, followed by hemodialysis and kidney transplantation. Each ESRD patient on hemodialysis costs ≈€40000 to €80000 per year, has extremely poor quality of life and an average life expectancy of onl ...
Read Project

 12

 FINISHED 
"Carbon capture and storage (CCS) is one of the technological solutions to decarbonize the energy market while providing secure energy supply. So far, the cost of CCS is dominated by the CO2 capture, reason why new capture techniques should be developed.Adsorption techniques have already been evaluated for CO2 capture. So far, the main drawbacks of this technique are the energetic demand to regene ...
Read Project

 12

 FINISHED 
Among patients with adrenal masses Adrenocortical carcinoma (ACC) and malignant pheochromocytomas (MPH) are found with a low incidence but very unfavorable prognosis. Due to this poor clinical outcome, concomitant hormone dysregulation and limited treatment options the two cancer entities severely impact on affected patients. However, the rarity of the tumors also impedes clinical studies which ar ...
Read Project

 17